Endometrial cells

Endometrial cells constitute the mucosal inner lining of the uterus, consisting of a functional layer that sheds during menstruation and a basal layer that facilitates regeneration. These cells are highly sensitive to ovarian steroid hormones; estrogen promotes their proliferation, while progesterone induces differentiation and decidualization in preparation for potential embryo implantation (StatPearls, 2023). From a drug discovery perspective, 'Endometrial cells' is an incorrect designation for a molecular target, as it refers to a complex tissue composed of multiple cell types (epithelial, stromal, and immune) rather than a specific protein or receptor (NIH, 2023). Pathological states involving these cells are clinically significant, including endometriosis, where endometrial-like tissue grows ectopically, and endometrial adenocarcinoma, which is the most common gynecologic malignancy in developed countries (PubMed, 2022). Therapeutic strategies typically involve modulating the activity of nuclear receptors within these cells to manage reproductive disorders or utilizing cytotoxic agents to treat malignancy (NCI, 2023).

Other names

EndometriumUterine lining cellsEndometrial epithelial cellsEndometrial stromal cells

Drugs do not target the cell as a single unit but rather interact with specific intracellular receptors (e.g., Estrogen Receptor, Progesterone Receptor) or signaling pathways within these cells to modulate gene transcription, inhibit proliferation, or induce apoptosis (StatPearls, 2023).